Osteoporosis: What a clinician expects to learn from a patient's bone density examination

Radiology

Volumn 228, Issue 3, 2003, Pages 620-628

  Lentle, Brian C ^a   Prior, Jerilynn C ^a  

^a NONE

Author keywords

Bones, absorptiometry; Bones, diseases; Osteoporosis; Subtraction, dual energy

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; ESTROGEN; PROGESTERONE;

BONE DENSITY; COMPUTER ASSISTED TOMOGRAPHY; DEMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DRUG EFFICACY; DUAL ENERGY X RAY ABSORPTIOMETRY; FOLLOW UP; FRAGILITY FRACTURE; HUMAN; INCIDENCE; LIFESTYLE; MORBIDITY; MORTALITY; OSTEOPOROSIS; QUALITY CONTROL; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

ABSORPTIOMETRY, PHOTON; BONE DENSITY; DENSITOMETRY, X-RAY; HUMANS; LUMBAR VERTEBRAE; OSTEOPOROSIS; THORACIC VERTEBRAE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0042431694     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2283020093     Document Type: Review

References (59)

1. Khosla S, Melton LJ III. Secondary osteoporosis. In: Riggs BL, Melton LJ III, eds. Osteoporosis: etiology, diagnosis, and management. 2nd ed. Philadelphia, Pa: Lippincott-Raven, 1995; 183-204.
2. World Health Organization. Assessment of osteoporotic fracture risk and its role in screening for postmenopausal osteoporosis. WHO Technical Report Series, no. 843. Geneva, Switzerland: World Health Organization, 1994; 5.
3. Harris ST, Watts N, Genant HK, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. JAMA 1999; 282:1344-1352.
4. Black DM, Thompson DE, Bauer DC, et al. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. J Clin Endocrinol Metab 2000; 85:4118-4124.
5. Miller PD, Bonnick SL, Rosen CJ, et al. Clinical utility of bone mass measurements in adults: consensus of an international panel. Semin Arthritis Rheum 1996; 25:361-372.
6. Miller PD, Bonnick SL, Rosen CJ, et al. Consensus of an international panel on the clinical utility of bone mass measurements in the detection of low bone mass in the adult population. Calcif Tissue Int 1996; 58:207-214.
7. Blake GM, Fogelman I. Technical principles of dual energy x-ray absorptiometry. Semin Nucl Med 1997; 27:210-228.
8. Baran DT, Faulkner KG, Genant HK, Miller PD, Pacifici R. Diagnosis and management of osteoporosis: guidelines for the utilization of bone densitometry. Calcif Tissue Int 1997; 61:433-440.
9. Compston JE, Cooper C, Kanis JA. Bone densitometry in clinical practice. BMJ 1995; 310:1507-1510.
10. Blake GM, Gluer CC, Fogelman I. Bone densitometry: current status and future prospects. Br J Radiol 1997; S177-S186.
11. Genant HK, Engelke K, Fuerst T, et al. Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res 1996; 11:707-730.
12. Jackson SA, Tenenhouse A, Robertson L. Vertebral fracture definition from population-based data: preliminary results from the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000; 11:680-687.
13. Duppe HR, Gardsell P, Nilsson B, Johnell O. A single bone density measurement can predict fractures over 25 years. Calcif Tissue Int 1997; 60:171-174.
14. Njeh CF, Boivin CM, Langton CM. The role of ultrasound in the assessment of osteoporosis: a review. Osteoporos Int 1997; 7:7-22.
15. Gregg EW, Ecriska AM, Salamone LM, et al. The epidemiology of quantitative ultrasound: a review of the relationships with bone mass, osteoporosis and fracture risk. Osteoporos Int 1997; 7:89-99.
16. Rang C, Speller R. Comparison of ultrasound and dual energy x-ray absorptiometry measurements in the calcaneus. Br J Radiol 1998; 71:861-867.
17. Salamone LM, Ecrall EA, Harris S, Dawson-Hughes B. Comparison of broadband ultrasound attenuation to single x-ray absorptiometry measurements at the calcaneus in postmenopausal women. Calcif Tissue Int 1994; 54:87-90.
18. Hans D, Dargent-Molina P, Schott AM. Ultrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective study. Lancet 1996; 348:511-514.
19. Hans D, Schott AM, Arlot ME, Sornay E, Delmas PD, Meunier PJ. Influence of anthropomorphic parameters on ultrasound measurements of os calcis. Osteoporos Int 1995; 5:371-376.
20. Johansen A, Stone MD. The effect of ankle edema on bone ultrasound assessment at the heel. Osteoporos Int 1997; 7:44-47.
21. Howard GM, Nguyen T, Pocock NA, Kelly PJ, Eisman JA. Influence of handedness on calcaneal ultrasound: implications for assessment of osteoporosis and study design. Osteoporos Int 1997; 7:190-194.
22. Yang SO, Hagiwara S, Engelke K, et al. Radiographic absorptiometry for bone mineral measurement of the phalanges: precision and accuracy study. Radiology 1994; 192:857-859.
23. Kleerekoper M. Nelson DA, Flynn MJ, et al. Comparison of radiographic absorptiometry with dual-energy x-ray absorptiometry and quantitative computed tomography in older white and black women. J Bone Miner Res 1994; 9:1745-1749.
24. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114:19-23.
25. Ross PD, Davis JW, Wasnich RD, Vogel JM. A critical review of bone mass and the risk of fractures in osteoporosis. Calcif Tissue Int 1990; 46:1149-1161.
26. Blake GM, Rea JA, Fogelman I. Vertebral morphometry studies using dual-energy x-ray absorptiometry. Semin Nucl Med 1997; 27:276-90.
27. Marshall D, Johnell O, Wedel H. Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures. BMJ 1996; 312:1254-1259.
28. Cummings SR, Black DM, Nevitt MC, et al. Bone density at various sites for prediction of fractures. Lancet 1993; 341:72-75.
29. Miller PD, Harris ST. Clinical applications of bone densitometry. In: Genant HK, Guglielmi G, Jergas M, eds. Bone densitometry in osteoporosis. Berlin, Germany: Springer-Verlag, 1998; 477-487.
30. Kanis JA. Assessment of bone mass in osteoporosis. In: Osteoporosis. Cambridge, Mass: Blackwell Science, 1994; 114-147.
31. Eddy DM, Johnston CC, Cummings SR, et al. Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Osteoporos Int 1998; 8(suppl 4):S1-S88.
32. Grampp S, Genant HK, Mathur A, et al. Comparisons of noninvasive bone mineral measurements in assessing age related loss, fracture discrimination, and diagnostic classification. J Bone Miner Res 1997; 12:697-711.
33. Mazess R, Chestnut C III, McClung M, Genant H. Enhanced precision with dual-energy x-ray absorptiometry. Calcif Tissue Int 1992; 51:14-17.
34. Rosenthall L. Estimation of the effect of a preinjection of Tc-99m MDP on lumbar spine bone mineral density determinations. Clin Nucl Med 1992; 17:195-197.
35. Orwoll ES, Oviatt SK, Mann T. The impact of osteophytic and vascular calcifications on vertebral mineral density measurements in men. J Clin Endocrinol Metab 1990; 70:1202-1207.
36. Jaovisidha S, Sartoris DJ, Martin EM, De Maeseneer M, Szollar SM, Deftos LJ. Influence of spondylopathy on bone densitometry using dual energy x-ray absorptiometry. Calcif Tissue Int 1997; 60:424-429.
37. Rand T, Seidl G, Kainberger F, et al. Impact of spinal degenerative changes on the evaluation of bone mineral density with dual energy x-ray absorpfiometry (DXA). Calcif Tissue Int 1997; 60:430-433.
38. Ryan PJ, Evans P, Blake GM, Fogelman I. The effect of vertebral collapse on spinal bone mineral density. Bone Miner 1992; 18:267-272.
39. Staron RB, Greenspan R, Miller TT, Bilezekian JP, Shane E. Computerized bone densitometric analysis: operator-dependent errors. Radiology 1999; 211:467-470.
40. Ettinger B, Black DM, Mitlak BH, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene. JAMA 1999; 282:637-645.
41. Glüer CC, Blake G, Lu Y, Blunt BA, Jergas M, Genant HK. Accurate assessment of precision errors: how to measure the reproducibility errors of bone densitometry techniques. Osteoporos Int 1995; 5:262-270.
42. He YF, Ross PD, Davis JW, Epstein RS, Vogel JM, Wasnich RD. When should bone mass measurements be repeated? Calcif Tissue Int 1994; 55:243-248.
43. Prior JC, Vigna YM, Wark JD, et al. Premenopausal ovariectomy-related bone loss: a randomized, double-blind one year trial of conjugated estrogen or medroxyprogesterone acetate. J Bone Miner Res 1997; 12:1851-1863.
44. Prior JC. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998; 19:397-428.
45. Jones CD, Laval-Jeantet AM, Laval-Jeantet MH, Genant HK. Importance of measurement of spongious vertebral bone mineral density in the assessment of osteoporosis. Bone 1987; 8:201-206.
46. Blake GM, Herd RJM, Fogelman I. A longitudinal study of supine lateral DXA of the lumbar spine: a comparison with posteroanterior spine, hip and total body DXA. Osteoporos Int 1996; 5:462-470.
47. Reid IR, Ames R, Evans MC, et al. Determinants of total body regional bone mineral density in normal postmenopausal women: a key role for fat mass. J Clin Endocrinol Metab 1992; 75:45-51.
48. Bolotin HH. A new perspective on the causal influence of soft tissue composition on DXA-measured in vivo bone mineral density. J Bone Miner Res 1998; 13:1739-1746.
49. Wahner HW, Fogelman I. Clinical bone density. London, England: Dunitz, 1994; 88-120.
50. Simmons A, Simpson DE, O'Doherty MJ, Barrington S, Coakley AJ. The effects of standardization and reference values on patient classification for spine and femur. Osteoporos Int 1997; 7:200-206.
51. Tenenhouse A, Joseph L, Krieger N, et al. Estimation of prevalence of low bone density in Canadian women and men using a population-specific DEXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int 2000; 11:897-904.
52. Lenchik L, Rochmis P, Sartoris DJ. Optimized interpretation and reporting of dual x-ray absorptiometry (DXA) scans. AJR Am J Roentgenol 1998; 171:1509-1520.
53. Stock JL, Waud CE, Coderre JA, et al. Clinical reporting to primary care physicians leads to increased use and understanding of bone densitometry and affects the management of osteoporosis: a randomized trial. Ann Intern Med 1998; 128:996-999.
54. Fuleihan GE, Stock JL, McClung MR, Saifi G. A national random survey of bone mineral density reporting in the United States. J Clin Densitom 2002; 5:3-9.
55. Hanson J. Standardization of femur BMD: International Committee for Standards in Bone Measurement. J Bone Miner Res 1997; 12:1316-1317.
56. Ray NF, Chan JK, Thamer M, Melton LJ. Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res 1997; 12:24-35.
57. Sturtridge W, Lentle B, Hanley DA. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 2. The use of bone density measurement in the diagnosis and management of osteoporosis. CMAJ 1996; 55:924-929.
58. Prior JC, Vigna YM, Barr SI, Rexworthy C, Lentle BC. Cyclic medroxyprogesterone treatment increases bone density: a controlled trial in active women with menstrual cycle disturbances. Am J Med 1994; 96:521-530.
59. Burr DR, Forwood MR, Fytirie DP, Martin RB, Schaffler MB, Turner CH. Bone microdamage and skeletal fragility in osteoporotic and stress fractures. J Bone Miner Res 1997; 12:6-15.